Cartelisation of drugs to stop: FDA

The decades-old fight over genetically modified food has reached a fever pitch in Washington. The Obama administration and Congress are weighing the safety of technological advances that seem ripped from science fiction, including salmon that can ...

The US Food and Drug Administration (FDA) has now issued a draft guideline on expanded access to investigational new drugs (IND) for treatment use in a 21 questions and answers format. The regulatory authority is now seeking the responses on this by ...

Aurobindo Pharma has received final approvals from the US Food and Drug Administration (US FDA) to manufacture and market tamsulosin hydrochloride capsules USP 0.4mg (ANDA 202433) and clindamycin palmitate hydrochloride for oral solution USP ...

The US Food and Drug Administration and National Food and Drug Administration and Control (NAFDAC) are tightening regulation of food and medicine products that originate from Nigeria. Dr Beverly Corey, senior regional advisor for sub-Saharan Africa ...

Pharma major Wockhardt plunged on Monday after media reports said, the US Food and Drugs Administration (USFDA) had issued a 483 form through a routine course of inspection for its injectables facility in Aurangabad. Shares of the company are trading at Rs ...

Sexual enhancement supplements could pose danger as they contain hidden drugs, warns the US Food and Drug Administration. According to the FDA, a supplement called "Stiff Days" contains sildenafil, the active ingredient in prescription drug Viagra, which is ...

Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced that the U.S. Food and Drug Administration (FDA) has issued this evening a Complete Response Letter (CRL) to its New Drug Application (NDA) for Probuphine®, the company's investigational subdermal ...

Actos (pioglitazone) is a Type 2 diabetes drugs that was approved by the U.S. Food and Drug Administration (FDA) in 1999. has filed a lawsuit on behalf of a South Dakota man who took the drug, and alleges that it caused his bladder cancer; the case ...

Synageva BioPharma Corp. (Synageva) has announced that the US Food and Drug Administration (FDA) granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency (LAL deficiency), also ...